Butterfly Network Income from Continuous Operations 2020-2025 | BFLY

Butterfly Network income from continuous operations from 2020 to 2025. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
Butterfly Network Annual Income from Continuous Operations
(Millions of US $)
2024 $-72
2023 $-134
2022 $-169
2021 $-32
2020 $-163
2019 $-100
Butterfly Network Quarterly Income from Continuous Operations
(Millions of US $)
2025-03-31 $-14
2024-12-31 $-18
2024-09-30 $-17
2024-06-30 $-16
2024-03-31 $-22
2023-12-31 $-44
2023-09-30 $-27
2023-06-30 $-29
2023-03-31 $-34
2022-12-31 $-34
2022-09-30 $-55
2022-06-30 $-36
2022-03-31 $-44
2021-12-31 $-15
2021-09-30 $-14
2021-06-30 $-3
2021-03-31 $-1
2020-12-31 $-23
2020-09-30 $-92
2020-06-30 $-23
2020-03-31 $-24
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.480B $0.082B
Butterfly Network Inc. created handheld, single-probe whole-body ultrasound system, Butterfly iQ. The company through its proprietary Ultrasound-On-Chip(TM) technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions. Butterfly Network Inc., formerly known as Longview Acquisition Corp., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $46.456B 59.10
Doximity (DOCS) United States $11.587B 53.64
Hims & Hers Health (HIMS) United States $10.739B 111.58
Tempus AI (TEM) United States $10.555B 0.00
IRhythm Technologies (IRTC) United States $4.548B 0.00
Inspire Medical Systems (INSP) United States $3.789B 59.21
Hinge Health (HNGE) United States $3.638B 0.00
Privia Health (PRVA) United States $2.696B 184.25
Enovis (ENOV) United States $1.922B 10.72
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.602B 0.00
Schrodinger (SDGR) United States $1.550B 0.00
Azenta (AZTA) United States $1.521B 70.70
Omnicell (OMCL) United States $1.398B 24.66
Evolent Health (EVH) United States $1.384B 117.90
Clover Health Investments (CLOV) United States $1.303B 0.00
Claritev (CTEV) United States $0.747B 0.00
Fulgent Genetics (FLGT) United States $0.611B 0.00
Veradigm (MDRX) United States $0.525B 0.00
Standard BioTools (LAB) United States $0.513B 0.00
Talkspace (TALK) United States $0.463B 138.50
Outset Medical (OM) United States $0.370B 0.00
TruBridge (TBRG) United States $0.343B 761.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.167B 0.00
American Well (AMWL) United States $0.133B 0.00
EUDA Health Holdings (EUDA) Singapore $0.126B 0.00
Pulmonx (LUNG) United States $0.112B 0.00
CareCloud (CCLD) United States $0.104B 3.97
MDxHealth SA (MDXH) Belgium $0.104B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.082B 0.00
111 (YI) China $0.064B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.060B 0.00
P3 Health Partners (PIII) United States $0.046B 0.00
HeartBeam (BEAT) United States $0.044B 0.00
Zepp Health (ZEPP) Netherlands $0.043B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.018B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00